Getting started
Duvyzat®
(givinostat)
This medicine is subject to additional monitoring and information about reporting side effects can be found at the bottom of this page.
All photographic images on this page feature real patients. They are shown for illustrative purposes only, and individual experiences may vary.
First steps towards success
How should you prepare and take the medicine?
Duvyzat® needs to be taken twice daily, so it must become part of a daily routine.
The medication must always be taken exactly as prescribed by the doctor.
If you have any doubts, ask the healthcare team.
The oral liquid is dosed and administered using a graduated syringe provided with the medication. The syringe should be rinsed with water after use – ready to reuse for each dose.
The precise dose of the medication is based on body weight and will be determined by your doctor. Be aware that the dosage may change during the course of treatment.
Try and take your medicine at the same time every day.
With a bit of practice, taking the medication will soon become a routine.
Instructions are available to download in the ‘Dosing instructions’ PDF and the ‘Duvyzat® administration video’ below. These provide detailed information about how to prepare and administer the medication.
Suitable viewing for all ages
Important
Preparing Duvyzat®
- Use Duvyzat® exactly as supplied in the bottle.
- Always use the syringe provided. Contact your healthcare team or pharmacist if you lose the syringe or throw it away by accident.
- If you forget a dose, simply continue with the next scheduled one. Do not take double to make up for a missed dose.
- If you take too much Duvyzat® by accident, contact your healthcare team or a hospital immediately.
Storage
- Do not use the medication after the expiry date stated on the packaging.
- After being opened Duvyzat® is stable for 60 days and must be discarded afterwards. It’s a good idea to write the date you opened the bottle either on it or on the outer carton.
- This medicinal product does not require any special temperature storage conditions.
Dosing instructions
Quick reference instructions are available to explain the process of administering Duvyzat®
Follow-up appointments
Regular check-ups help ensure the treatment is safely managed
During the regular follow-up appointments your blood values will continue to be checked, in addition to any other tests your health team recommend.
For some tests, it may be necessary to fast – check before the appointment whether it’s okay to eat beforehand.
Interactions with other medications
Make a note
Make a list of all your medications and supplements to tell your healthcare team.
Further support and information
Monitoring, safety and side effects
Important safety information
Support booklets
Tailored booklets can be downloaded here, or from the bottom of the home page, where you will also find additional information.
This website is designed to be a growing resource, and we are committed to making it as helpful and informative as possible for everyone who visits. Over time, new content will be added to provide practical tips, detailed guidance, and useful resources that support learning and understanding.
These updates will include information to help answer common questions, and share tools that make navigating treatment easier. Because new material will be introduced, returning to the website from time to time will ensure access to the latest updates and resources available.
Reporting side effects
Your safety matters – here’s how to report concerns
Instructions for reporting side effects via MHRA Yellow Card are shown below.
You can also refer to the instructions in the patient information leaflet regarding how to report side effects.
Reporting of side effects:
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at: https://yellowcard.mhra.gov.uk
By reporting side effects, you can help provide more information on the safety of this medicine. This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See https://yellowcard.mhra.gov.uk for how to report side effects.
